Back to Search Start Over

Potential Therapeutic Strategies for Skeletal Muscle Atrophy.

Authors :
Huang, Li
Li, Ming
Deng, Chunyan
Qiu, Jiayi
Wang, Kexin
Chang, Mengyuan
Zhou, Songlin
Gu, Yun
Shen, Yuntian
Wang, Wei
Huang, Ziwei
Sun, Hualin
Source :
Antioxidants; Jan2023, Vol. 12 Issue 1, p44, 30p
Publication Year :
2023

Abstract

The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people's quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle atrophy owing to an incomplete understanding of its molecular mechanisms. Exercise therapy is the most effective treatment for skeletal muscle atrophy. Unfortunately, it is not suitable for all patients, such as fractured patients and bedridden patients with nerve damage. Therefore, understanding the molecular mechanism of skeletal muscle atrophy is crucial for developing new therapies for skeletal muscle atrophy. In this review, PubMed was systematically screened for articles that appeared in the past 5 years about potential therapeutic strategies for skeletal muscle atrophy. Herein, we summarize the roles of inflammation, oxidative stress, ubiquitin-proteasome system, autophagic-lysosomal pathway, caspases, and calpains in skeletal muscle atrophy and systematically expound the potential drug targets and therapeutic progress against skeletal muscle atrophy. This review focuses on current treatments and strategies for skeletal muscle atrophy, including drug treatment (active substances of traditional Chinese medicine, chemical drugs, antioxidants, enzyme and enzyme inhibitors, hormone drugs, etc.), gene therapy, stem cell and exosome therapy (muscle-derived stem cells, non-myogenic stem cells, and exosomes), cytokine therapy, physical therapy (electroacupuncture, electrical stimulation, optogenetic technology, heat therapy, and low-level laser therapy), nutrition support (protein, essential amino acids, creatine, β-hydroxy-β-methylbutyrate, and vitamin D), and other therapies (biomaterial adjuvant therapy, intestinal microbial regulation, and oxygen supplementation). Considering many treatments have been developed for skeletal muscle atrophy, we propose a combination of proper treatments for individual needs, which may yield better treatment outcomes. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20763921
Volume :
12
Issue :
1
Database :
Complementary Index
Journal :
Antioxidants
Publication Type :
Academic Journal
Accession number :
161421951
Full Text :
https://doi.org/10.3390/antiox12010044